Showing results (1221-1230 of 2,355) with videos related to

Sort By:
Pageof 236
Proceedings of the National Academy of Sciences of the United States of America|July 8, 1998
Targeted expansion of genetically modified bone marrow cellsL Jin, N Siritanaratkul, D W Emery, et al.
Nature Cell Biology|July 18, 2018
NKX3-1 is required for induced pluripotent stem cell reprogramming and can replace OCT4 in mouse and human iPSC inductionThach Mai, Glenn J Markov, Jennifer J Brady, et al.
Nature|June 29, 2017
Corrigendum: Dermatologist-level classification of skin cancer with deep neural networksAndre Esteva, Brett Kuprel, Roberto A Novoa, et al.
Child: Care, Health and Development|June 23, 2007
Microbial contamination of nebulizers in the home treatment of cystic fibrosisH Blau, H Mussaffi, M Mei Zahav, et al.
Journal of Nanoscience and Nanotechnology|April 2, 2010
Ferromagnetic behaviour of nickel contacted multiwalled carbon nanotubesE Titus, M K Singh, Gil Cabral, et al.
Nephron|January 1, 1996
Successful treatment of secondary hyperparathyroidism in hemodialysis patients with oral pulse 1-alpha-hydroxy-cholecalciferol therapyJ Rapoport, M Mostoslavski, A Ben-David, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 27, 2015
Stereotactic interstitial brachytherapy for the treatment of oligodendroglial brain tumorsFaycal El Majdoub, Clemens Neudorfer, Tobias Blau, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|April 30, 2026
Strabismus or prior successfully treated amblyopia does not impair binocular reading speed in adolescentsGuy Barnett-Itzhaki, Etti Libovits, Zohar Barnett-Itzhaki, et al.
BMC Cancer|May 7, 2015
High-recovery visual identification and single-cell retrieval of circulating tumor cells for genomic analysis using a dual-technology platform integrated with automated immunofluorescence stainingDaniel E Campton, Arturo B Ramirez, Joshua J Nordberg, et al.
Investigational New Drugs|November 17, 2010
In vitro cytotoxicity of the novel antimyeloma agents perifosine, bortezomib and lenalidomide against different cell linesMartin Schmidt-Hieber, Robert Dabrowski, Andreas Weimann, et al.
Pageof 236